CRF2 receptor-deficiency eliminates opiate withdrawal distress without impairing stress coping
CRF2 receptor-deficiency eliminates opiate withdrawal distress without impairing stress coping
复制标题
DOI:
10.1038/mp.2011.119
复制
发表时间:
2012-12-01
影响因子:
11
通讯作者:
Contarino, A.
中科院分区:
文献类型:
--
作者:
Ingallinesi, M.;Rouibi, K.;Contarino, A.
The opiate withdrawal syndrome is a severe stressor that powerfully triggers addictive drug intake. However, no treatment yet exists that effectively relieves opiate withdrawal distress and spares stress-coping abilities. The corticotropin-releasing factor (CRF) system mediates the stress response, but its role in opiate withdrawal distress and bodily strategies aimed to cope with is unknown. CRF-like signaling is transmitted by two receptor pathways, termed CRF1 and CRF2. Here, we report that CRF2 receptor-deficient (CRF2-/-) mice lack the dysphoria-like and the anhedonia-like states of opiate withdrawal. Moreover, in CRF2-/- mice opiate withdrawal does not increase the activity of brain dynorphin, CRF and periaqueductal gray circuitry, which are major substrates of opiate withdrawal distress. Nevertheless, CRF2 receptor-deficiency does not impair brain, neuroendocrine and autonomic stress-coping responses to opiate withdrawal. The present findings point to the CRF2 receptor pathway as a unique target to relieve opiate withdrawal distress without impairing stress-coping abilities. Molecular Psychiatry (2012) 17, 1283-1294; doi:10.1038/mp.2011.119; published online 27 September 2011